nisoxetine has been researched along with metaraminol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuller, RW; Perry, KW; Snoddy, HD | 1 |
| Fuller, RW; Gehlert, DR; Hemrick-Luecke, SK; Howbert, JJ; Krushinski, J; Robertson, DW; Schober, DA; Wong, DT | 1 |
2 other study(ies) available for nisoxetine and metaraminol
| Article | Year |
|---|---|
Nisoxetine antagonism of norepinephrine depletion in brain and heart after alpha-methyl-m-tyrosine administration.
Topics: Animals; Brain Chemistry; Fluoxetine; Male; Metaraminol; Methyltyrosines; Myocardium; Norepinephrine; Phenyl Ethers; Propylamines; Rats; Tyramine | 1979 |
(R)-thionisoxetine, a potent and selective inhibitor of central and peripheral norepinephrine uptake.
Topics: Animals; Carrier Proteins; Cerebral Cortex; Fluoxetine; Hypothalamus; Isomerism; Male; Metaraminol; Myocardium; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Peripheral Nervous System; Rats; Rats, Sprague-Dawley; Serotonin; Symporters; Synaptosomes; Urethra | 1995 |